Equity, Diversity, & Inclusion Committee

The main function of the Equity, Diversity and Inclusion (EDI) Committee is to monitor and report on the progress of the BioCanRx EDI Action Plan. The committee will act in an advisory capacity to the BioCanRx Board of Directors with respect to EDI matters. The EDI Committee includes two members of BioCanRx’s Board of Directors, and three members external to the Board who are experts in the area of equity, diversity and inclusion related to the science academic sector.

 

Members of the committee

 

eborenstein
Ela Borenstein (Chair)
Program Director
Business Development Bank of Canada (BDC)
Gillian Carleton
PhD Student, University of Victoria
Dr. Tina Gruosso
Scientist, Forbius
Aaron Prosper
Project Manager, Nova Scotia Mi’kmaw Nation Cancer Care Strategy
Graduate Student, University of Prince Edward Island
Dr. John Stagg
Associate Professor, Faculty of Pharmacy at the University of Montreal
Lab Head at the CHUM Hospital Research Centre

 

BioCanRx Staff

 

 
Dr. Stéphanie Michaud, President and Chief Executive Officer Dr. Megan Mahoney, Director, Scientific Affairs and Training Programs Ms. Laurie Cameron, Manager, Knowledge Mobilization & Corporate Operations  

 

Observer

 

Representative, Networks of Centres of Excellence